Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion.
Autor: | Cai CL; Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China., Zhang MQ, Guo J, Wang LW, Zhao JQ, Guo WJ, Mu XD |
---|---|
Jazyk: | angličtina |
Zdroj: | Chinese medical journal [Chin Med J (Engl)] 2019 Dec 20; Vol. 132 (24), pp. 3003-3005. |
DOI: | 10.1097/CM9.0000000000000556 |
Databáze: | MEDLINE |
Externí odkaz: |